Navigation Links
Parental perceptions are preventing HPV vaccination success
Date:10/21/2013

ROCHESTER, Minn. -- A Mayo Clinic physician and two other pediatric experts say that parental perceptions pose a major barrier to acceptance of human papillomavirus (HPV) vaccination and that many of those perceptions are wrong. Their comments are published in Expert Review of Clinical Immunology, in an editorial on why HPV vaccination rates remain poor.

"The greatest misperception of parents is that the HPV vaccine isn't needed," says Mayo Clinic's Robert Jacobson, M.D., pediatrician in the Mayo Clinic Children's Center and lead author of the editorial. "Not only is that wrong, it's a dangerous idea to be spreading around. Recent figures show that at least 12,000 unvaccinated women develop cervical cancer from HPV every year." Other incorrect perceptions: The HPV vaccines are not safe, and they are given to children when they are too young.

Dr. Jacobson's co-authors are James Roberts, M.D., M.P.H., Medical University of South Carolina, and Paul Darden, M.D., University of Oklahoma Health Sciences Center.

What should physicians do?

Overcoming these parental perceptions will take more than what physicians are doing now, the authors say. Traditional attempts to provide information are not enough. Clinicians must engage parents in conversations to learn what the parents' concerns are, share with the parents how the clinicians have learned what they know, summarize the science addressing the parental concerns, and passionately communicate their recommendations based on that engagement, their professional standing, and the science. Clinicians also will need to find ways to reach out to the parents of adolescents outside of the exam room because many of their patients that age rarely make visits to the office. Social media may very well play an important role in the future of HPV vaccination programs.

Currently available vaccines include Gardasil (Merck & Co.) and Cervarix (GlaxoSmithKline). The vaccines prevent cancers caused by the virus HPV. In the United States, about 21,000 individuals develop such cancers each year, including cancer of the cervix. Despite universal recommendations for use since 2006, rates in 13- to 17-year-old females in the U.S. for completing the three-dose series hovered around 35 percent for 2011 and 2012.

More than half of individuals living in the U.S. will otherwise become infected with HPV, a disease transmitted by sexual contact. Most clear the infection over a two-year period, but those who do not develop precancerous and cancerous cells leading to the 21,000 cancers a year.

The authors point out that HPV vaccines were found safe before they were licensed for production, and follow-up studies since conducted in hundreds of thousands of recipients continue to support that finding. Furthermore, the vaccines require three doses to be given over three months. While the Advisory Committee on Immunization Practices recommends the vaccines for 11- to 12-year-olds, that committee gives permission to clinicians to begin vaccinating at age 9. The vaccines give long-lasting immunity, and the younger children have a better response to the vaccine than older adolescents or young adults. Vaccinating when the adolescents are young completes the series long before exposure and takes advantage of their better immune response.


'/>"/>

Contact: Bob Nellis
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. Parental consent for HPV vaccine should not be waived, poll says
2. Making Parental Peace With Kids Homework
3. Review: Altruisms influence on parental decision to vaccinate children is unclear
4. Trickle-down anxiety: Study examines parental behaviors that create anxious children
5. Diet, parental behavior, and preschool can boost childrens IQ
6. Pre-College Parental Chat May Reduce Freshman Drinking
7. Parental addictions linked to adult childrens depression
8. New BUSM study explores providers perceptions of parental concerns about HPV vaccination
9. Ethical quandary about vaccinations sparked by tension between parental rights and protecting public health
10. Abuse, lack of parental warmth in childhood linked to multiple health risks in adulthood
11. Penn researchers find error reporting improves perceptions of safety and may reduce incidents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... Bellus Medical, ... latest innovation in the delivery of Platelet Rich Plasma (PRP). PRP systems are ... management, to accelerate tissue synthesis and provide a faster and more efficient healing ...
(Date:2/22/2017)... Athens, GA (PRWEB) , ... February 22, 2017 , ... ... Feb. 25 and 26 event in Athens, Georgia. , A shift from Super-Sod’s simple ... made in Georgia. , For the booth, grass seed plant manager Chris Roquemore constructed ...
(Date:2/22/2017)... ... February 22, 2017 , ... In ... many different solutions on the market, it is easy to start feeling frustrated ... Locksmith offers a complimentary security consultation. , Home Security Hardware Choices, There ...
(Date:2/21/2017)... Australia (PRWEB) , ... February 22, 2017 , ... Author ... it is valuable for every household and family to know all about it for ... publishing world with the release of “ Detox, Digestive and Wellness Solutions ” (published ...
(Date:2/21/2017)... ... February 21, 2017 , ... As recently as 2015, rhinoplasty was one of ... of Plastic Surgeons. Some patients want to make a change in the appearance of ... their breathing ability. The team at usrhinoplasty.org is expanding its article database ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... 2017  Applied Silver, the maker of SilvaClean®, today announced ... advisory board. Ms. Barnes is the company,s third Clinical Advisor ... and healthcare experts Scott McNealy , Josh McQueen ... J. Tress Ritter , and Leopold Selker . ... than three decades of nationally recognized clinical, nursing, and infection ...
(Date:2/22/2017)... Feb. 22, 2017 Oncternal Therapeutics, Inc., ... both rare and common malignancies, today announced the ... The company intends to use the proceeds to ... and to advance preclinical development of a new ... is a first-in-class anti-ROR1 monoclonal antibody being developed ...
(Date:2/22/2017)... BEACH, Florida , February 22, 2017 /PRNewswire/ ... Cannabis Industries is becoming more and more prevalent ... Of Cannabinoids & THC Extracts as well as ... approach to medicinal cannabis and marijuana therapies and ... acquiring new relationships and assets designed to bring ...
Breaking Medicine Technology: